BIO PARTNERS LP 3
3 · BIOSPECIFICS TECHNOLOGIES CORP · Filed Jun 20, 2003
Insider Transaction Report
Form 3
No transactions or holdings reported in this filing.
Footnotes (1)
- [F1]Reporting Person may exercise, at a conversion price (subject to various typical adjustments) of $2.50 per share of Common Stock of Biospecifics Technologies Corp., up to $1,141,875 of the aggregate principal amount of the Convertible Note. If the Reporting Person fully exercised such conversion rights, the Reporting Person would recieve 456,750 shares of the Common Stock of Biospecifics Technologies Corp.